Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by gojotv!on Jan 24, 2022 12:44pm
129 Views
Post# 34353589

RE:RE:RE:RE:Aristotle testing volumes and daily schedule

RE:RE:RE:RE:Aristotle testing volumes and daily scheduleHahaha, silly geese!
Look at the page and read again... It's clear that this is the internet booking site only. It doesn't include the numbers, probably higher, of those who prefer to call in to request an appointment... See? The phone number is on the page. It says, "call OR book by internet". What we see here are the 15 spots/day reserved to internet bookings.
AND these are only the numbers for the U.S. and Canada.
But best of all, there's a little scroll-wheel on the top right-hand corner of the grid.
See that?
They are clearly beta-testing the site with small numbers in anticipation of massive future growth by location. After all, they have to reserve phlebotomists to collect blood.
Very clever of SZLS to start their internet bookings small and get it right.
Reading the signs puts your guesstimates on the low end. We are looking at a manifestation of burgeoning demand.
Chugging along nicely... GLTA!



LithLover wrote: I am sure they will add more case managers with the next hub and spoke roll out of a new location.

15 appointments at 2/3 booked is $6 million in annual revenue.  As they bring on other locations this will only increase.

Down to only 11 appointments left this week. Was 25 yesterday and 90 at the start of last week.  


Pacman28 wrote:
why do we only book 15 appointments a day when the demand seems to be there?




<< Previous
Bullboard Posts
Next >>